I now have extensive content from multiple authoritative surgical textbooks. Here is the comprehensive answer:
Intestinal Stomas and Enterocutaneous Fistulas: Types, Management, and Complications
PART 1: INTESTINAL STOMAS
Definition and Purpose
A stoma is a surgically created opening between a hollow viscus and the skin surface. It may be used as a definitive procedure, as a guide to further treatment, or as salvage from a failed or complicated prior surgical intervention. - Bailey and Love's Short Practice of Surgery, 28th ed.
Classification of Stomas
Stomas can be differentiated along several axes (Sabiston Textbook of Surgery):
1. By Bowel Segment
- Ileostomy - from small bowel (ileum); produces liquid to semi-liquid effluent; requires spouted/everted construction (Brooke ileostomy) to prevent skin damage from digestive enzymes
- Colostomy - from large bowel; effluent becomes progressively more formed depending on the site:
- Ascending colostomy: liquid effluent
- Transverse colostomy: semi-formed
- Descending/sigmoid colostomy: formed stool; preferred for permanent diversion
2. By Configuration
- End stoma - bowel is divided; the proximal end is brought to the skin. The distal end is either brought out as a mucus fistula or closed and left in the abdomen (Hartmann's pouch).
- Loop stoma - a loop of bowel is brought through the wall; a rod or bridge keeps it above the skin level. Provides diversion but is temporary; loop ileostomy is preferred over loop transverse colostomy because transverse loop colostomies are large, prone to prolapse, and difficult to pouch.
- Double-barrel stoma - both proximal and distal limbs are brought to the skin surface as two separate openings; used in emergency cases, significant inflammation, or when a standard loop cannot be safely created.
- End-loop (end-loop ileostomy) - hybrid configuration.
3. By Duration
- Temporary stoma - used to protect a distal anastomosis, manage sepsis, or allow healing of distal pathology. Anticipated to be closed later.
- Ghost ileostomy: a loop of ileum is prepared and marked but sutured beneath the skin without being made functional; converted to a functional ileostomy quickly if an anastomotic leak occurs post-operatively.
- Permanent stoma - required when bowel continuity cannot be restored (e.g., abdominoperineal resection for rectal cancer, end-stage IBD, permanent incontinence, or bedridden patients).
4. By Content Drained
- Enteric stomas (stool)
- Urinary conduits (urostomies): e.g., ileal conduit
5. By Continence
- Incontinent stoma - standard; stool drains freely into an appliance
- Continent stoma - e.g., Koch pouch (continent ileostomy) - an internal reservoir with a nipple valve; the patient catheterizes the pouch to empty it
Stoma Siting
Pre-operative marking by an enterostomal therapist is essential. The ideal site is within the rectus abdominis muscle, away from the belt line, umbilicus, bony prominences, skin creases, scars, and wounds. The infraumbilical fat mound is the ideal site in many patients. Poor siting is a primary preventable cause of stoma complications, including retraction and pouching failure.
Stoma Construction Technique
- A disk of skin 1.5-2 cm in diameter is excised
- The rectus muscle is split (muscle-splitting approach); the rectus sheath is sharply divided
- The aperture should admit two fingers (typical diameter)
- Blood supply is tested before and after passing bowel through the wall
- Ileostomies are matured with eversion (Brooke technique): 2-3 cm of bowel is everted to form a spout, directing the corrosive effluent away from the skin
- Colostomies need protrude only 0.5-1 cm above the skin level
Stoma Complications
Up to 30% of patients require operative revision for stoma complications. - Fischer's Mastery of Surgery, 8th ed.
Early Complications
| Complication | Key Points |
|---|
| Necrosis/Ischemia | First 24-72 hrs; stoma turns dark/cyanotic. Caused by skeletonizing distal bowel, tight fascial defect, or tension on mesentery. If necrosis extends below the fascia: surgical re-exploration and new stoma. If above fascia only: manage expectantly. |
| Bleeding | From stoma mucosa or mesenteric vessels |
| Retraction | Stoma pulls back to or below skin level. Causes: tension from obesity, mesenteric edema, poor siting. Management: convex appliance, stoma belt; local revision or relocation for persistent cases |
| Peristomal skin irritation | Leakage of effluent (especially liquid small-bowel content) under the appliance |
| Obstruction | At fascia level or intra-abdominally |
Late Complications
Stenosis
- Can occur at skin or fascial level, or both
- Early causes: inadequate skin opening, ischemia, mucocutaneous separation, abscess
- Late causes: Crohn's disease, malignancy, scarring
- Symptoms: obstructive symptoms, squirting of stool under pressure
- Management: gentle digital dilation, low-residue diet; severe cases require surgical revision
Prolapse
- More common with loop colostomies; almost always the efferent limb prolapses
- Associated with parastomal hernia
- Rare after ileostomy
Parastomal Hernia
- The most common late complication of colostomy
- Bowel/omentum protrudes through the abdominal wall fascial defect adjacent to the stoma
- Symptoms: poor appliance fitting, pain, obstruction, strangulation
- Management: symptomatic hernias require repair
- Simple suture repair: nearly 100% recurrence rate
- Mesh repair (open or laparoscopic): preferred
- Stoma relocation to opposite side
- Prophylactic mesh at time of stoma creation: decreases parastomal hernia risk by ~40% per a meta-analysis of 12 RCTs, though recent RCTs show less benefit
Peristomal Skin Complications (Fischer's Mastery of Surgery):
- Irritant/contact dermatitis: confluent erythema from effluent leakage; treated by proper appliance fitting and barrier products
- Allergic dermatitis: patch testing to identify allergen
- Pseudoverrucous lesions: warty hyperkeratotic overgrowth from chronic irritation; treated with silver nitrate
- Candidiasis: bright red pustular rash in moist area; topical antifungal powder
- Cellulitis: oral/topical antibiotics
- Folliculitis: from traumatic hair removal; proper clipping technique
- Pyoderma gangrenosum: rare; may be associated with IBD
Fistulation - an abnormal tract forms from bowel to skin adjacent to the stoma
Metabolic Complications (mainly ileostomy)
- Dehydration and electrolyte abnormalities (bypasses colon's water-absorbing capacity)
- Target output <1500 mL/day; managed with bulk agents, loperamide, codeine, tincture of opium, or octreotide
- Calcium oxalate urinary stones
- Gallstones (altered bile salt metabolism)
PART 2: ENTEROCUTANEOUS FISTULA (ECF)
Definition
An enterocutaneous fistula is an abnormal connection between the intestinal epithelium and the skin. It is an external fistula, as distinct from internal fistulas (enteroenteric, enterovesical, enterovaginal). - Schwartz's Principles of Surgery, 11th ed.
Classification of Intestinal Fistulas
A. By Communication (Location)
| Type | Description |
|---|
| Enterocutaneous (ECF) | Small/large bowel to skin |
| Colocutaneous | Colon to skin (e.g., from diverticular disease) |
| Enteroatmospheric | Bowel opening directly into an open wound/abdomen; most severe form - no fistula tract |
| Enterovesical | Bowel to bladder; causes pneumaturia, fecaluria, recurrent UTIs |
| Enterovaginal/Rectovaginal | Bowel to vagina |
| Enteroenteric | Bowel loop to bowel loop; may cause malabsorption by bypassing bowel |
| Enterocolonic | Small bowel to colon |
B. By Output Volume (Fischer's Mastery of Surgery):
| Category | Volume/day |
|---|
| Low output | < 200 mL/day |
| Moderate output | 200-500 mL/day |
| High output | > 500 mL/day |
Some sources use >500 mL/day as the threshold for high-output (Bailey and Love). High-output fistulas - especially proximal small bowel - cause major dehydration, electrolyte disturbances, and malnutrition.
C. By Etiology
- Iatrogenic (>80%): anastomotic leak, inadvertent enterotomy during adhesiolysis (frequency increases with each laparotomy), or hernia repair mesh erosion
- Spontaneous: Crohn's disease, diverticulitis, malignancy, radiation enteritis, appendicitis, pancreatitis, peptic ulcer disease
D. By Complexity
- Simple - single tract, no abscess, no associated distal obstruction
- Complex - multiple openings, enteroatmospheric, associated with abscesses, radiation damage, or open abdomen
Etiology in Detail
Iatrogenic (postoperative): The single most common cause. ECFs become clinically evident between the 5th and 10th postoperative days with fever, leukocytosis, prolonged ileus, abdominal tenderness, and wound infection/discharge. At least 50% follow surgery in which no small bowel was resected, due to injury during adhesiolysis. - Bailey and Love
Crohn's disease: Most common spontaneous cause. Medication optimization (biologics, immunomodulators) can sometimes achieve closure. However, fistulas can reoccur once enteral nutrition is resumed after closure with bowel rest.
Diverticular disease: Spontaneous or after drain placement for complicated diverticulitis; may produce colocutaneous fistulas. All persistent fistulas require surgery; malignancy must be excluded by colonoscopy.
Radiation damage: Fistulas from radiation (gynecologic, rectal, prostate cancers) are unlikely to close spontaneously; nearby tissue may be damaged and unsuitable for anastomosis.
Malignancy: Requires surgery for closure, but often in advanced disease; staging determines operability.
Mesh-related ECF: After herniorrhaphy; unlikely to close spontaneously. Requires fistula repair + mesh removal + abdominal wall reconstruction.
Factors Preventing Spontaneous Fistula Closure
(Mnemonic: FRIENDS - Fischer/Maingot)
| Factor | Details |
|---|
| Foreign body | Mesh, sutures |
| Radiation | Radiation-damaged bowel |
| Infection/sepsis | Local or systemic |
| Epithelialization | Mature fistula tract epithelialized |
| Neoplasm | Malignant origin |
| Distal obstruction | Downstream stenosis prevents closure |
| Short tract / large defect | <2 cm tract or >1 cm bowel wall defect |
Additional factors: malnutrition (hypoalbuminaemia), IBD, high output, jejunal origin, multiple fistula openings, open abdomen.
Clinical Presentation
- Acute phase (postoperative): Fever, leukocytosis, wound erythema/discharge. The first sign is often a serosanguinous then enteric fluid from the wound between days 5-10.
- Chronic/spontaneous ECF: Presents with drain/wound discharge recognizable as enteric content; may have weight loss, malnutrition, and signs of sepsis.
- Peristomal/pericutaneous skin excoriation - especially with proximal small bowel content (high enzyme content).
- High-output fistulas cause rapid fluid/electrolyte losses: hyponatraemia, hypokalaemia, hypomagnesaemia, metabolic acidosis.
Diagnosis
- CT abdomen with oral/IV contrast - First-line investigation; identifies the fistula tract, any intra-abdominal abscesses, and associated pathology.
- Small bowel series or enteroclysis - Demonstrates the bowel segment of origin; rules out distal obstruction.
- Fistulogram - Contrast injected through a catheter into the fistula tract under pressure; most sensitive for tract anatomy when CT is non-diagnostic. Essential for surgical planning.
- Endoscopy - To evaluate for IBD, malignancy, or distal obstruction.
Management
The management of ECF follows a structured sequence. Two well-established frameworks are:
Framework 1: SNAP (Bailey and Love)
- S - Elimination of Sepsis and Skin protection
- N - Nutrition (parenteral or enteral depending on fistula level and output)
- A - Anatomical assessment (imaging, fistulography)
- P - Definitive Planned surgery
Framework 2: The Five Phases (Maingot's Abdominal Operations / Evenson & Fischer)
Phase 1: Recognition and Stabilization
- IV fluid resuscitation; correct electrolyte abnormalities
- Drain abscesses percutaneously (CT-guided)
- Antibiotics for sepsis
- Skin protection: hydrocolloid barriers, ostomy appliances, or wound ostomy continence (WOCN) nurse involvement
- Quantify output, establish fistula category
Phase 2: Investigation
- CT, small bowel series, fistulogram
- Define the bowel segment of origin, length of fistula tract, any distal obstruction, associated abscess
- Critical because distal fibrostenotic disease will prevent spontaneous closure
Phase 3: Decision / Optimization
- Establish timeline for conservative management (typically 4-6 weeks of optimized nutrition)
- Decide on route of nutrition
- Optimize medications (especially in IBD - biologics consideration)
- Identify non-modifiable factors (radiation, malignancy, mesh) that make spontaneous closure unlikely
Phase 4: Definitive Management (Surgery)
- Time: surgery should NOT be performed early in a septic, malnourished patient - "an early return to theatre in a septic, malnourished patient is doomed to failure" - Bailey and Love
- Anastomosis should be avoided if:
- Continuing intra-abdominal sepsis
- Hypoalbuminaemia (<32 g/dL)
- Operative approach: enter abdomen through previously unoperated area (cephalad or caudad to prior incision); inadvertent enterotomy occurs in ~20% of reoperations
- Resect the fistula-bearing bowel segment and restore continuity; avoid anastomosis in a hostile abdomen
Phase 5: Rehabilitation
- Long-term nutritional and ostomy/wound support
- Psychological support
Nutritional Management (Key Component)
Route selection:
- High-output or proximal fistula: Total Parenteral Nutrition (TPN) is preferred; reduces fistula output, allows bowel rest, supports spontaneous closure without increasing mortality. Protein target: 1.5-2.0 g/kg/day (higher with greater output).
- Low-output or distal fistula (<200 mL/day or distal bowel): Trial of enteral nutrition (EN) with careful monitoring for increased output.
- Fistuloclysis: Feeding through the fistula itself (re-infusion of enteric contents and tube feeds via the fistula opening, distally). Can replace TPN when spontaneous closure is unlikely and distal bowel is accessible.
Pharmacological adjuncts:
- Octreotide (somatostatin analogue): Reduces secretion and fistula output; particularly useful in high-output fistulas. A meta-analysis confirmed reduced hospital stay and time to closure with somatostatin, though ultimate closure rates were not significantly different. - Schwartz's Principles of Surgery
- Antibiotics: Ciprofloxacin + metronidazole (or rifaximin) for aerobic and anaerobic gut flora coverage, especially in home therapy scenarios.
- Biologics (in IBD-related ECF): Anti-TNF agents (infliximab) can induce fistula closure.
Wound Care / Skin Protection
- Simple ECF: managed like a stoma with hydrocolloid barrier and appliance
- Vacuum-assisted closure (VAC/NPWT):
- Low-output ECF: >85% closure rates with VAC devices
- High-output ECF: lower success rates; fistulas with visible mucosa are unlikely to close
- Also used for enteroatmospheric fistulas with modified sump tube systems
- Complex/enteroatmospheric fistulas require involvement of WOCN nurses and complex wound management strategies
Spontaneous Closure Rates
Reported in 10-75% of patients (wide range due to referral bias in specialty centers). Spontaneous closure typically occurs within 4-6 weeks of optimized conservative management.
Complications of ECF
| Complication | Mechanism |
|---|
| Malnutrition/cachexia | Ongoing protein and caloric losses through the fistula |
| Dehydration | High fluid losses, especially proximal high-output fistulas |
| Electrolyte disturbances | Hyponatraemia, hypokalaemia, hypomagnesaemia, metabolic acidosis |
| Sepsis | Intra-abdominal abscesses, peritonitis, wound infection |
| Peristomal skin excoriation | Digestive enzyme content causes chemical burns |
| Prolonged TPN dependence | Catheter-related bloodstream infection (CRBSI), liver disease, metabolic bone disease |
| Psychological morbidity | Chronic wound, dependency, social isolation |
| Mortality | Historical rates 40-60%; modern series 5-20% with modern supportive care |
Summary Comparison: Stoma vs. ECF
| Feature | Intestinal Stoma | Enterocutaneous Fistula |
|---|
| Nature | Surgically intended bowel-to-skin opening | Abnormal, usually unintended communication |
| Origin | Planned surgical creation | Anastomotic leak, enterotomy, IBD, malignancy |
| Output control | Managed with appliance | Difficult; requires wound care team |
| Spontaneous closure | N/A (permanent or planned reversal) | Possible in 10-75% with conservative care |
| Skin risk | Peristomal dermatitis | Excoriation/chemical burn from effluent |
| Nutritional impact | Mainly ileostomy fluid/electrolyte loss | Severe with high-output proximal ECF |
| Definitive Rx | Reversal or permanent | Conservative (SNAP/5 phases) or surgical resection |
Sources:
- Bailey and Love's Short Practice of Surgery, 28th ed., Ch. 74
- Schwartz's Principles of Surgery, 11th ed., Ch. 28
- Sabiston Textbook of Surgery, Ch. 95
- Fischer's Mastery of Surgery, 8th ed., Ch. 130, 142, 143
- Maingot's Abdominal Operations, Ch. 10
- Current Surgical Therapy, 14th ed.
- Yamada's Textbook of Gastroenterology, 7th ed.